Drammen Sykehus

Futó vizsgálatok

• Toboroz

  A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.

  NCT07753993· 3. fázis· Forrás

• Fut, nem toboroz

  Weight Loss in People Living With Overweight or Obesity Following Treatment With Cagrilintide

  NCT07220642· 3. fázis· Forrás

• Toboroz

  Antiplatelet therapy added to standard thromboprophylaxis to prevent thrombosis in pancreatic cancer patients - a randomized clinical trial (The PANART trial)

  2023-509022-22-00· 3. fázis· Forrás

• Toboroz

  Thrombolysis in Factor Xa-inhibitors Trial

  NCT06878066· 3. fázis· Forrás

• Fut, nem toboroz

  Effect of proactive therapeutic drug monitoring on maintenance of sustained disease control in adults with rheumatoid arthritis on a subcutaneous TNF inhibitor: The Rheumatoid Arthritis therapeutic DRUg Monitoring trial (RA-DRUM)

  2023-510184-35-00· 4. fázis· Forrás

• Toboroz

  DESTINY Breast Respond HER2-(Ultra)Low Europe

  NCT05945732· Forrás

• Toboroz

  SACK

  2022-501600-10-00· 3. fázis· Forrás

• Toboroz

  Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress

  NCT03968393· 4. fázis· Forrás

• Fut, nem toboroz

  An open-label extension study evaluating long-term safety, tolerability and effectiveness of ofatumumab in subjects with RMS

  2023-507906-15-00· 3. fázis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Pitvarfibrilláció3 toboroz
• Krónikus vesebetegség2 toboroz
• Stroke (szélütés)2 toboroz
• Áttétes emlőrák1 toboroz
• Hasnyálmirigyrák1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Lezárult

  The TAF-MS study

  2023-503814-62-00· 2. fázis· Forrás

• Fut, nem toboroz

  A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast Cancer

  NCT05654623· 3. fázis· Forrás

• Lezárult

  A study to learn how well the study treatment asundexian works and how safe it is compared to apixaban to prevent stroke or systemic embolism in people with irregular and often rapid heartbeat (atrial fibrillation), and at risk for stroke

  NCT05643573· 3. fázis· Forrás